Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using New Genetic Technology to Diagnose Neurodevelopmental Disorders

NCT02227381 is registered in ClinicalTrials.gov with Manchester University NHS Foundation Trust as lead sponsor.

NCT NCT02227381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02227381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using New Genetic Technology to Diagnose Neurodevelopmental Disorders
Lead sponsor
Manchester University NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
February 28, 2011
Completion date
June 30, 2015
Enrollment
119 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

learning disabilities